CBPL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Upcoming Events:
Quarterly Results
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Chandra Bhagat Pharm do?
Chandra Bhagat Pharma Pvt Ltd specializes in providing a range of life-saving medicines in India through its diverse portfolio, including cardiovascular drugs, antibiotics, and neurology drugs.
Who are the competitors of Chandra Bhagat Pharm?
Chandra Bhagat Pharm major competitors are Unick Fix-A-Form, Ishita Drugs & Inds., Medistep Healthcare, Medicamen Organics, Venmax Drugs&Pharma, Omkar Pharmachem, Adeshwar Meditex. Market Cap of Chandra Bhagat Pharm is ₹25 Crs. While the median market cap of its peers are ₹26 Crs.
Is Chandra Bhagat Pharm financially stable compared to its competitors?
Chandra Bhagat Pharm seems to be less financially stable compared to its competitors. Altman Z score of Chandra Bhagat Pharm is 1.48 and is ranked 7 out of its 8 competitors.
Does Chandra Bhagat Pharm pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Chandra Bhagat Pharm latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Chandra Bhagat Pharm allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Short Term Loans & Advances
How strong is Chandra Bhagat Pharm balance sheet?
Chandra Bhagat Pharm balance sheet is weak and might have solvency issues
Is the profitablity of Chandra Bhagat Pharm improving?
No, profit is decreasing. The profit of Chandra Bhagat Pharm is ₹0.62 Crs for TTM, ₹0.86 Crs for Mar 2025 and ₹1.53 Crs for Mar 2024.
Is the debt of Chandra Bhagat Pharm increasing or decreasing?
The net debt of Chandra Bhagat Pharm is decreasing. Latest net debt of Chandra Bhagat Pharm is ₹19.73 Crs as of Sep-25. This is less than Mar-25 when it was ₹19.75 Crs.
Is Chandra Bhagat Pharm stock expensive?
Chandra Bhagat Pharm is not expensive. Latest PE of Chandra Bhagat Pharm is 31.93, while 3 year average PE is 135. Also latest EV/EBITDA of Chandra Bhagat Pharm is 0 while 3yr average is 32.02.
Has the share price of Chandra Bhagat Pharm grown faster than its competition?
Chandra Bhagat Pharm has given lower returns compared to its competitors. Chandra Bhagat Pharm has grown at ~-41.07% over the last 1yrs while peers have grown at a median rate of -6.0%
Is the promoter bullish about Chandra Bhagat Pharm?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 73.02% and last quarter promoter holding is 72.19%.
Are mutual funds buying/selling Chandra Bhagat Pharm?
There is Insufficient data to gauge this.